Atlas Trials

Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study

Clinical trial NCT02514499 · COMPLETED

Trial details

NCT number
NCT02514499
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
BRCA1/2 Negative
Start date
2014-07-01
Primary completion
2018-10-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.